Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions (Q26765051)

Mario Raviglione

27

0 references

Stephen Squire

S Bertel Squire

21

0 references

Knut Lönnroth

2

Knut Lönnroth

0 references

Soumya Swaminathan

22

Soumya Swaminathan

0 references

Gilla Kaplan

11

Gilla Kaplan

0 references

Claudia Denkinger

8

Claudia M Denkinger

0 references

Thomas G. Evans

9

Thomas G Evans

0 references

Paul van Helden

23

Paul D Van Helden

0 references

Diana Weil

26

Diana Weil

0 references

Christian Lienhardt

1

Christian Lienhardt

0 references

author name string

Manica Balasegaram

4

0 references

Jeremiah Chakaya

5

0 references

Frank Cobelens

6

0 references

Jennifer Cohn

7

0 references

Gunilla Källenius

10

0 references

Ajay M V Kumar

12

0 references

Line Matthiessen

13

0 references

Charles S Mgone

14

0 references

Ya-Diul Mukadi

16

0 references

Viet Nhung Nguyen

17

0 references

Anders Nordström

18

0 references

Christine F Sizemore

19

0 references

Melvin Spigelman

20

0 references

Karin Weyer

Creative Commons Attribution 4.0 International

25

0 references

language of work or name

English

0 references

publication date

March 2016

0 references

1 March 2016

12 references

23 March 2019

21 June 2019

20 June 2019

22 June 2019

27 May 2020

28 May 2020

4 June 2020

28 July 2020

8 September 2020

22 September 2020

3 November 2020

23 October 2022

12 references

23 March 2019

21 June 2019

20 June 2019

22 June 2019

27 May 2020

28 May 2020

4 June 2020

28 July 2020

8 September 2020

22 September 2020

3 November 2020

23 October 2022

13

0 references

issue

3

0 references

page(s)

e1001965

0 references

copyright license

11 references

23 March 2019

21 June 2019

20 June 2019

22 June 2019

27 May 2020

28 May 2020

28 July 2020

8 September 2020

22 September 2020

3 November 2020

on focus list of Wikimedia project

23 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

The role of biomedical research in global tuberculosis control: gaps and challenges: A perspective from the US National Institute of Allergy and Infectious Diseases, National Institutes of Health

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

High-dose rifapentine with moxifloxacin for pulmonary tuberculosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

A four-month gatifloxacin-containing regimen for treating tuberculosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Global health 2035: a world converging within a generation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Preventive vaccines for tuberculosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Global tuberculosis control: lessons learnt and future prospects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Tuberculosis vaccines: a strategic blueprint for the next decade

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Modeling social, environmental and biological determinants of tuberculosis.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Indicators of sustainable capacity building for health research: analysis of four African case studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Tuberculosis: what we don't know can, and does, hurt us.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Drivers of tuberculosis epidemics: the role of risk factors and social determinants

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Eliminating human tuberculosis in the twenty-first century

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

Evaluating health research capacity building: an evidence-based tool

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4775029

WHO's new end TB strategy.

28 September 2017

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001965

LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001965

Innovative Trial Designs Are Practical Solutions for Improving the Treatment of Tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001965

Fundamental research is the key to eliminating TB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001965

Tuberculosis diagnostics: which target product profiles should be prioritised?

21 January 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PMED.1001965

Operational research for improved tuberculosis control: the scope, the needs and the way forward

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26933883

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Two decades of research on tuberculosis in Brazil: state of the art of scientific publications]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26933883

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tuberculosis control and elimination 2010–50: cure, care, and social development

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26933883

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1371/JOURNAL.PMED.1001965

1 reference

2724715

2724715

1 reference

1 reference

1 reference